A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis

Jae Hyun Jung, Sung Eun Kim, Hak Jun Kim, Kyeongsoon Park, Gwan Gyu Song, Sung Jae Choi

    Research output: Contribution to journalArticlepeer-review

    20 Citations (Scopus)


    Diacerein (DIA) is a slow-acting drug for osteoarthritis (OA). Oral DIA administration, however, exerts side effects including diarrhea and urine discoloration. We fabricated DIA-loaded poly(d,l-lactide-co-glycolide) nanoparticles (DIA/PLGA NPs) that allow sustained release of DIA. In vitro, rat synoviocytes were used to investigate the cytotoxicity and anti-inflammatory effects of DIA-loaded NPs. In vivo, monosodium iodoacetate (MIA)-induced OA rats were divided into seven groups that included non-treated healthy control rats and rats injected with MIA alone or in combination with NPs, DIA(5%) solution, DIA(1%)/NPs, DIA(5%)/NPs, or oral DIA. The in vitro studies revealed that DIA/PLGA NPs dose-dependently suppressed mRNA levels of pro-inflammatory cytokines and enzymes, including interleukin-1 (IL-1), IL-6, tumor necrosis factor-α, matrix metalloproteinase-3 (MMP-3), MMP-13, cyclo-oxygenase-2, and a disintegrin and metalloproteinase with thrombospondin motifs-5 in synoviocytes. The in vivo studies demonstrated that intra-articular treatment of OA rat models with DIA-loaded PLGA NPs markedly decreased mRNA levels of these pro-inflammatory factors and increased those of anti-inflammatory cytokines (IL-4 and IL-10). Micro-computed tomography and histological evaluations indicated that intra-articular injection of DIA-loaded NPs was effective in protecting against cartilage degradation. Administration of DIA/PLGA NPs via intra-articular injection is promising for inhibiting inflammation and protecting against cartilage degradation in OA.

    Original languageEnglish
    Article number119249
    JournalInternational Journal of Pharmaceutics
    Publication statusPublished - 2020 May 15

    Bibliographical note

    Funding Information:
    The research was supported by a Korea University Grant (grant number: O1801501 ) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2018R1D1A1B07050687 ).

    Publisher Copyright:
    © 2020 Elsevier B.V.


    • Anti-inflammation
    • Diacerein
    • Intra-articular injection
    • Poly(D,L-lactide-co-glycolide)
    • Sustained drug delivery

    ASJC Scopus subject areas

    • Pharmaceutical Science


    Dive into the research topics of 'A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis'. Together they form a unique fingerprint.

    Cite this